logo-loader
RNS
Salt Lake Potash Ltd

Salt Lake Potash Ltd - Result of AGM. Issue of Equity. Appendix 3B

RNS Number : 9323S
Salt Lake Potash Limited
11 November 2019
 

11 November 2019

 

AIM/ASX Code: SO4

 

 

SALT LAKE POTASH LIMITED

Results of Annual General Meeting

Corporate Presentation

Issue of Equity

Appendix 3B

 

 

AIM and ASX listed Salt Lake Potash Limited ("the Company") advises that at the Annual General Meeting of shareholders held earlier today, 11 November 2019, at 11.00am (WST), all resolutions were duly passed.

 

The resolutions voted on were in accordance with the Notice of Annual General Meeting announced on 11 October 2019.

In accordance with Section 251AA of the Corporations Act 2001, the following information is also provided:

 

Resolution

Result

Number of Proxy Votes

For

Against

Abstain

Proxy's Discretion

1.  Remuneration Report

Passed unanimously on a show of hands

44,977,186

4,877,880

15,750,000

2,802,202

2.  Re-election of Director - Mr Bryn Jones

Passed unanimously on a show of hands

65,605,066

-

-

2,802,202

3.  Ratification of August 2019 Placement Shares

Passed unanimously on a show of hands

60,727,186

181,102

4,696,778

2,802,202

4.  Ratification of Placement Fee Shares

Passed unanimously on a show of hands

65,598,066

7,000

-

2,802,202

5.  Ratification of Consultant Options

Passed unanimously on a show of hands

65,598,066

7,000

-

2,802,202

6.  Ratification of Facility Options

Passed unanimously on a show of hands

65,605,066

-

-

2,802,202

7.  Issue of Taurus Options

Passed unanimously on a show of hands

65,423,964

181,102

-

2,802,202

8.  Issue of Advisor Options

Passed unanimously on a show of hands

62,998,066

7,000

2,600,000

2,802,202

9.  Issue of Shares to Mr Tony Swiericzuk

Passed unanimously on a show of hands

65,498,066

107,000

-

2,802,202

10.       Issue of Employee Options

Passed unanimously on a show of hands

60,801,288

4,803,778

-

2,802,202

11.       Approval of Employee Equity Incentive Plan

Passed unanimously on a show of hands

60,747,288

4,803,778

54,000

2,802,202

12.       Issue of Performance Rights to Mr Tony Swiericzuk

Passed unanimously on a show of hands

60,798,134

4,806,932

-

2,802,202

13.       Approval of Additional 10% Placement Capacity

Passed unanimously on a show of hands

65,427,810

177,256

-

2,802,202

 

The Company released a new Corporate Presentation for the Annual General Meeting which is available to view on www.so4.com.au.

 

Issue of Securities

Following the Annual General Meeting, the Company has also released an Appendix 3B on the Australian Securities Exchange ("ASX"), as required under the ASX Listing Rules following the issue of securities, including:

-      266,258 ordinary shares of no par value ("Ordinary Shares") to the CEO, Mr Tony Swiericzuk (following receipt of shareholder approval) in lieu of vested performance rights that the Company was unable to convert prior to expiry.

-      17,635 Ordinary Shares to a consultant in partial satisfaction of fees owing.

-      472,500 Ordinary Shares to employees, consultants and directors on conversion of performance rights following satisfaction of the BFS Milestone. Mr Mark Pearce and Mr Bryn Jones, Directors, each received 50,000 Ordinary Shares on conversion of these performance rights.

-      288,324 performance rights to the CEO Mr Tony Swiericzuk (following receipt of shareholder approval) vesting on 30 June 2020 and expiring 31 December 2020.

-      4,852,074 performance rights with various milestones to key employees and consultants.

-      4,200,000 incentive options to key employees.

-      1,000,000 unlisted options to a key advisor.

Settlement and dealings

Application will be made to the AIM Market of the London Stock Exchange ("AIM") for 756,393 Ordinary Shares, which rank pari passu with the Company's existing issued Ordinary Shares, to be admitted to trading. Dealings on AIM are expected to commence at 8:00am on or around 14 November 2019 ("Admission").

Total Voting Rights

For the purposes of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules ("DTRs"), following Admission, Salt Lake will have 256,743,373 Ordinary Shares in issue with voting rights attached. Salt Lake holds no shares in treasury. This figure of 256,743,373 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the ASX Listing Rules or the DTRs.

Directors' interests

Following the issue of these shares, the directors will have the following interests in shares:

 

 

Number of shares

Percentage of issued share capital

Tony Swiericzuk

1,218,639

0.47%

Mark Pearce

4,050,000

1.58%

Bryn Jones

50,000

0.02%

 

Mr Swiericzuk also holds an indirect interest in 5 million incentive options and 7,288,324 performance rights.

Mr Pearce also holds a direct interest in 100,000 performance rights.

Mr Jones also holds a direct interest in 100,000 performance rights.

 

 

For further information please visit www.so4.com.au or contact:

Clint McGhie

Salt Lake Potash Limited

Tel: +61 8 6559 5800

Colin Aaronson/Richard Tonthat/Ben Roberts

Grant Thornton UK LLP (Nominated Adviser)

Tel: +44 (0) 20 7383 5100

 

 

 

 

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

 

New issue announcement,

application for quotation of additional securities

and agreement

 

Information or documents not available now must be given to ASX as soon as available.  Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96  Origin: Appendix 5  Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

 

 

Name of entity

 SALT LAKE POTASH LIMITED

 

ABN

 98 117 085 748

 

We (the entity) give ASX the following information.

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1

+Class of +securities issued or to be issued

 

(a)   Ordinary Shares

(b)   Ordinary Shares

(c)   Ordinary Shares

(d)   Incentive Options

(e)   Incentive Options

(f)    Incentive Options

(g)   Unlisted Options

(h)   Performance Rights

(i)    Performance Rights

 

 

 

 

 

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

 

(a)   266,258

(b)   472,500

(c)   17,635

(d)   300,000

(e)   1,900,000

(f)    2,000,000

(g)   1,000,000

(h)   288,324

(i)    4,852,074

 

 

 

 

 

3

Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

(a)   Fully paid ordinary shares

(b)   Fully paid ordinary shares

(c)   Fully paid ordinary shares

(d)   Incentive options exercisable for $0.60 each on or before 1 November 2023

(e)   Incentive options exercisable for $1.00 each on or before 1 November 2023

(f)    Incentive options exercisable for $1.20 each on or before 1 November 2023

(g)   Unlisted options exercisable for $0.702 each on or before 30 June 2023

(h)   Performance rights subject to short term incentive milestone expiring 31 December 2020.

(i)    Performance rights which are subject to various performance conditions to be satisfied prior to the relevant expiry dates between 1 November 2020 and 1 November 2023

 

 

 

 

4

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

 

If the additional +securities do not rank equally, please state:

·    the date from which they do

·    the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

·    the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

(a)   Yes

(b)   Yes

(c)   Yes

(d)   No - Not listed

(e)   No - Not listed

(f)    No - Not listed

(g)   No - Not listed

(h)   No - Not listed

(i)    No - Not listed

 

 

 

 

5

Issue price or consideration

 

(a)   Nil

(b)   Nil

(c)   $12,000

(d)   Nil

(e)   Nil

(f)    Nil

(g)   $100

(h)   Nil

(i)    Nil

 

 

 

 

 

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

 

 

(a)   Issue of shares following Shareholder approval in lieu of vested performance rights that were unable to be converted prior to expiry.

(b)   Conversion of performance rights following satisfaction of the BFS milestone.

(c)   Issue of shares to consultant in partial consideration for fee.

(d)   Issue of incentive options to key employees pursuant to their service agreements with the Company.

(e)   Issue of incentive options to key employees pursuant to their service agreements with the Company.

(f)    Issue of incentive options to key employees pursuant to their service agreements with the Company.

(g)   Issue of unlisted options to advisor in relation to advisory services provided on the Company's debt financing.

(h)   Issue of performance rights to the CEO following Shareholder approval.

(i)    Issue of performance rights to key employees and consultants in accordance with the Company's Employee Equity Incentive Plan.

 

 

 

 

 

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

Yes

 

 

 

 

 

6b

The date the security holder resolution under rule 7.1A was passed

11 November 2019

 

 

 

 

 

6c

Number of +securities issued without security holder approval under rule 7.1

1,017,635

 

 

 

 

 

 

6d

Number of +securities issued with security holder approval under rule 7.1A

Nil

 

 

 

 

 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

4,754,582 (11 November 2019)

 

 

 

 

 

 

6f

Number of +securities issued under an exception in rule 7.2

5,324,574

 

 

 

 

 

6g

If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3?  Include the +issue date and both values.  Include the source of the VWAP calculation.

Not Applicable

 

 

 

 

 

 

6h

If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

Not Applicable

 

 

 

 

 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

7.1 - 36,629,710

7.1A - 25,597,659

 

 

 

 

7

+Issue dates

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12).  For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

11 November 2019

 

 

 

 

 

Number

+Class

8

Number and +class of all +securities quoted on ASX (including the +securities in section 2 if applicable)

256,743,373

Ordinary Shares

           

 

 

 

Number

+Class

9

Number and +class of all +securities not quoted on ASX (including the +securities in section 2 if applicable)

 

 

 

7,500,000

 

10,000,000

 

750,000

 

 

1,000,000

 

 

250,000

 

 

500,000

 

 

750,000

 

 

400,000

 

 

9,375,000

 

 

2,000,000

 

 

 

4,650,000

 

 

 

5,000,000

 

 

 

1,000,000

 

 

 

9,000,000

 

 

 

24,930,398

 

Class B Performance Shares

 

Class C Performance Shares

 

Incentive Options exercise price $0.50, expiry date 29 April 2020

 

Incentive Options exercise price $0.60, expiry date 29 April 2021

 

Incentive Options exercise price $0.40, expiry date 30 June 2021

 

Incentive Options exercise price $0.50, expiry date 30 June 2021

 

Incentive Options exercise price $0.60, expiry date 30 June 2021

 

Incentive Options exercise price $0.70, expiry date 30 June 2021

 

Unlisted Options exercise price $0.85, expiry date 30 June 2023

 

Incentive Options exercise price $0.60, expiry date 1 November 2023

 

Incentive Options exercise price $1.00, expiry date 1 November 2023

 

Incentive Options exercise price $1.20, expiry date 1 November 2023

 

Unlisted Options exercise price $0.702, expiry date 30 June 2023

 

Unlisted Options exercise price $0.702, expiry date 4 August 2024

 

Performance rights which are subject to various performance conditions to be satisfied prior to the relevant expiry dates between 31 December 2019 and 1 November 2023

 

 

 

10

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

Not Applicable

 

Part 2 ‑ Pro rata issue

 

11

Is security holder approval required?

 

Not Applicable

 

 

 

12

Is the issue renounceable or non-renounceable?

Not Applicable

 

 

 

13

Ratio in which the +securities will be offered

Not Applicable

 

 

 

14

+Class of +securities to which the offer relates

Not Applicable

 

 

 

15

+Record date to determine entitlements

Not Applicable

 

 

 

 

16

Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?

Not Applicable

 

 

 

17

Policy for deciding entitlements in relation to fractions

 

Not Applicable

 

 

 

18

Names of countries in which the entity has security holders who will not be sent new offer documents

Note: Security holders must be told how their entitlements are to be dealt with.

Cross reference: rule 7.7.

Not Applicable

 

 

 

19

Closing date for receipt of acceptances or renunciations

Not Applicable

 

 

 

 

20

Names of any underwriters

 

 

Not Applicable

 

 

 

21

Amount of any underwriting fee or commission

Not Applicable

 

 

 

22

Names of any brokers to the issue

 

 

Not Applicable

 

 

 

23

Fee or commission payable to the broker to the issue

Not Applicable

 

 

 

24

Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders

Not Applicable

 

 

 

25

If the issue is contingent on security holders' approval, the date of the meeting

Not Applicable

 

 

 

26

Date entitlement and acceptance form and offer documents will be sent to persons entitled

Not Applicable

 

 

 

27

If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders

Not Applicable

 

 

 

28

Date rights trading will begin (if applicable)

Not Applicable

 

 

 

29

Date rights trading will end (if applicable)

 

 

Not Applicable

 

 

 

30

How do security holders sell their entitlements in full through a broker?

Not Applicable

 

 

 

31

How do security holders sell part of their entitlements through a broker and accept for the balance?

Not Applicable

 

 

 

 

 

32

How do security holders dispose of their entitlements (except by sale through a broker)?

Not Applicable

 

 

 

33

+Issue date

 

 

Not Applicable

 

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

34

Type of +securities

(tick one)

 

(a)

X

+Securities described in Part 1

 

 

 

 

(b)

 

All other +securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

Entities that have ticked box 34(a)

 

Additional securities forming a new class of securities

 

 

Tick to indicate you are providing the information or documents

 

 

 

35

 

If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders

 

 

 

36

 

If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over

 

 

 

37

 

A copy of any trust deed for the additional +securities

 

 

Entities that have ticked box 34(b)

 

38

Number of +securities for which +quotation is sought

 

Not Applicable

 

 

 

 

 

39

+Class of +securities for which quotation is sought

 

Not Applicable

 

 

 

 

 

40

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

 

If the additional +securities do not rank equally, please state:

·    the date from which they do

·    the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

·    the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Not Applicable

 

 

 

 

 

41

Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

 

(if issued upon conversion of another +security, clearly identify that other +security)

 

Not Applicable

 

 

 

 

 

 

 

Number

+Class

42

Number and +class of all +securities quoted on ASX (including the +securities in clause 38)

 

 

 

 

 

         

 

 

 

Quotation agreement

 

1              +Quotation of our additional +securities is in ASX's absolute discretion.  ASX may quote the +securities on any conditions it decides. 

 

2              We warrant the following to ASX.

 

 

 

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

·              Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

 

3              We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4              We give ASX the information and documents required by this form.  If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins.  We acknowledge that ASX is relying on the information and documents.  We warrant that they are (will be) true and complete.

 

 

Sign here:              ...........................................................     Date: 11 November 2019

                                (Director/Company secretary)

 

 

Print name:            Clint McGhie

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGLIFERLSLLLIA
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

13 min read